AI in Botulinum Toxin Injections Points to a Broader Procedural Medicine Shift
A Cureus mini-review examines how AI is being applied to botulinum toxin injections, including planning, targeting, and outcome optimization. While the immediate focus is cosmetic and procedural care, the bigger trend is AI’s spread into more hands-on medical specialties.
AI in procedural medicine is a different challenge from AI in text-heavy specialties. Botulinum toxin injections depend on anatomy, technique, and patient-specific variation, so the real promise lies in helping clinicians make better spatial and dosing decisions.
The review is notable because it captures an early stage of translational adoption. In this setting, AI may support pre-procedure planning, image interpretation, or standardization of technique before it becomes part of higher-risk interventions.
That said, procedural AI is vulnerable to exaggerated claims. A tool that looks useful in a controlled setting may be much harder to trust when a clinician is working in real time and the consequences of a miss are visible immediately.
The broader takeaway is that AI is moving beyond documentation and diagnosis into the mechanics of treatment itself. That expansion will likely bring new efficiencies, but it will also demand stronger evidence, tighter oversight, and clearer boundaries around when assistance becomes dependence.